Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01752751 · ClinicalTrials.gov registry record
Predicting Tolerance to Radiation Therapy in Older Adults With Cancer
A clinical trial of Pre-treatment Loss of Independent Activities of Daily Living, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT01752751: Completed study of Pre-treatment Loss of Independent Activities of Daily Living, sponsored by UNC Lineberger Comprehensive Cancer Center.
NCT01752751 is a study of Pre-treatment Loss of Independent Activities of Daily Living that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01752751, a study of Pre-treatment Loss of Independent Activities of Daily Living, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
A comprehensive geriatric assessment tool developed by Hurria and colleagues has been used in non-radiation oncology clinical settings to predict how older adults tolerate cancer treatments. The investigators think this same tool (referred to as the CGA) can be used in a radiation oncology clinic to predict for poor treatment tolerance.
Primary Outcome
To assess the association between pre-treatment loss of at least one independent activity of daily living (I-ADL) on the CGA and poor tolerance to radiation therapy
Conditions Studied
Study Locations (1)
North Carolina
- Radiation Oncology Clinic - UNC Cancer Hospital - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-03 |
What the finished NCT01752751 record still lists
NCT01752751 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with Pre-treatment Loss of Independent Activities of Daily Living appearing as the primary indexed condition, and to 0 interventions.
NCT01752751 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01752751 about?
NCT01752751 is a clinical study titled "Predicting Tolerance to Radiation Therapy in Older Adults With Cancer". A comprehensive geriatric assessment tool developed by Hurria and colleagues has been used in non-radiation oncology clinical settings to predict how older adults tolerate cancer treatments. The investigators think this same tool (referred to as the CGA) can be used in a radiation oncology clinic to...
What is the current status of trial NCT01752751?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2012-11. Estimated completion is 2015-03.
What conditions does trial NCT01752751 study?
This clinical trial studies the following conditions: Pre-treatment Loss of Independent Activities of Daily Living.
Who is sponsoring clinical trial NCT01752751?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01752751 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia